Compare MINE & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MINE | LFMD |
|---|---|---|
| Founded | 2019 | 1994 |
| Country | Canada | United States |
| Employees | 6 | 384 |
| Industry | Oil & Gas Production | Medical/Nursing Services |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 211.7M | 190.9M |
| IPO Year | N/A | N/A |
| Metric | MINE | LFMD |
|---|---|---|
| Price | $2.96 | $4.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $9.14 |
| AVG Volume (30 Days) | 26.4K | ★ 1.1M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $17.52 |
| Revenue Next Year | N/A | $18.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.77 | $2.60 |
| 52 Week High | $4.45 | $15.34 |
| Indicator | MINE | LFMD |
|---|---|---|
| Relative Strength Index (RSI) | 40.28 | 66.90 |
| Support Level | N/A | $3.39 |
| Resistance Level | $4.38 | $6.49 |
| Average True Range (ATR) | 0.16 | 0.40 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 19.05 | 91.07 |
Mayfair Gold Corp is a mineral exploration company that is engaged in the acquisition and exploration of mineral properties. It has one material mineral property, the Fenn-Gib Gold Property, located in the Guibord, Munro, Michaud, and McCool Townships in northeast Ontario, which is in the exploration stage.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.